Barx2 may mediate ras/raf dependent transcription of the calcitonin gene via a ras/raf responsive promoter element and loss of Barx2-mediated differentiation may lead to loss of expression of the calcitonin marker, further resulting in MTC tumor progression [11, 28, 29]. This evidence concerns the gene BARX2 and medullary thyroid gland carcinoma.